The Risk of Cancer Associated with Anti-Diabetic Agents

被引：0
|
作者：
Zhang, Hui-Talia [1 ,2 ]
Hammad, Tarek A. [2 ]
Christiani, David [1 ]
Giovannuci, Edward [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
    Singh, Siddharth
    Singh, Preet Paul
    Singh, Abha Goyal
    Murad, Mohammad Hassan
    Sanchez, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06): : 881 - 891
  • [42] Anti-Diabetic Medications and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis
    Singh, Siddharth
    Singh, Harkirat
    Singh, Preet Paul
    Murad, Mohammad H.
    Limburg, Paul J.
    GASTROENTEROLOGY, 2013, 144 (05) : S18 - S18
  • [43] Assessing the Effect of Treatment Duration on the Association between Anti-Diabetic Medication and Cancer Risk
    But, Anna
    Wang, Haining
    Mannisto, Satu
    Pukkala, Eero
    Haukka, Jari
    PLOS ONE, 2014, 9 (11):
  • [44] The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes
    Liao, K-F
    Lai, S-W
    Lin, C-Y
    Huang, C-H
    Chu, Y-C
    Lin, Y-Y
    Hsu, F-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 115 - 115
  • [45] Factors Affecting the Association of Cancer Risk among Patients Treated with Anti-Diabetic Medication
    But, Anna
    Wang, Haining
    De Bruin, Marie L.
    Mannisto, Satu
    Haukka, Jari
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 215 - 215
  • [46] Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
    Hagberg, K. W.
    McGlynn, K. A.
    Sahasrabuddhe, V. V.
    Jick, S.
    BRITISH JOURNAL OF CANCER, 2014, 111 (09) : 1710 - 1717
  • [47] Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
    Lai, Shih-Wei
    Chen, Pei-Chun
    Liao, Kuan-Fu
    Muo, Chih-Hsin
    Lin, Cheng-Chieh
    Sung, Fung-Chang
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01): : 46 - 52
  • [48] Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
    K W Hagberg
    K A McGlynn
    V V Sahasrabuddhe
    S Jick
    British Journal of Cancer, 2014, 111 : 1710 - 1717
  • [49] Risk of Preeclampsia among Live Births Exposed to Anti-diabetic Agents during the First Trimester of Pregnancy
    Knox, Caitlin A.
    Hampp, Christian
    Brumback, Babette
    Xu, Xiaohui
    Segal, Richard
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 249 - 250
  • [50] SELECTIVE VPAC-2 LIGANDS AS POTENTIAL ANTI-DIABETIC AGENTS
    Alsina, J.
    Bokvist, K.
    Zhang, L.
    Cummins, R.
    Vick, A.
    Brenner, M.
    Mayer, J.
    BIOPOLYMERS, 2009, 92 (04) : 355 - 355
12345